Study to Demonstrate the Safety and Effectiveness of Benralizumab in Patients with Eosinophilic Gastritis and/or Gastroenteritis

Age
18 years - 99 years
Gender
All
participants needed
230
Location
1
Find a site

Brief description of study

This study aims to learn more about: if an experimental medication called benralizumab could be effective and safe in treating EG/EGE and also to better understand the studied disease and associated health problems.

Detailed description of study

This study aims to learn more about: if an experimental medication called benralizumab could be effective and safe in treating EG/EGE and also to better understand the studied disease and associated health problems.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Eosinophilic Gastritis, Gastroenteritis
  • Age: 18 years - 99 years
  • Gender: All

Diagnosed with Eosinophilic Gastritis and / or Gastroenteritis

Updated on 04 Aug 2024. Study ID: 849353

Find a site

We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact
Please provide your preferred way of contact
Other language

Interested in the study

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center